Core Outcome Measures in Effectiveness Trials

Methods for surveillance of antimalarial drug efficacy

General Information

Abstract:
Routine monitoring of antimalarial drug efficacy is necessary for effective case management and early detection of resistance. WHO recommends that the efficacy of first and second-line antimalarial treatments be tested at least once every 24 months at all sentinel sites. When studies are conducted according to a standard protocol over a period of time, the data provides a key resource for informing national treatment policy.

Authors:
World Health Organization (WHO)

Publication

Journal:
Volume:
Issue:
Pages:
-
Year:
2009
DOI:
Further Study Information

Date:
2005 - 2008
Funding source(s):

Health Area

Disease Category
Infectious disease

Disease Name
Malaria

Target Population

Age Range
-

Sex
Either


Nature / type of Intervention
Drug

Method(s)

Semi structured discussion

Stakeholders Involved

Not Specified

Study Type

Recommendations made

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.